Patents by Inventor William R. Moore

William R. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120210764
    Abstract: Disclosed herein is a sheet metal stamping device and method for substantially inhibiting recoil from a neutral stamped position of a scrap part region. A sheet metal stamping device for stamping a sheet metal part comprising a first die body and a second is provided wherein the first die body and the second die body are in operable communication for forming the sheet metal part from a sheet metal blank. The sheet metal part includes at least one scrap region formed therein which is prone to recoil from a neutral stamped position. The first die body and the second die body have complementary elongate bead-forming regions located for forming an elongate bead region in the scrap region. And, the elongate bead-forming regions are configured such that the elongate bead substantially inhibits recoil or springback of the scrap region from the neutral stamped position when the scrap region is severed from the part.
    Type: Application
    Filed: June 29, 2010
    Publication date: August 23, 2012
    Applicant: HONDA MOTOR CO., LTD.
    Inventor: William R. MOORE
  • Patent number: 7612200
    Abstract: The present invention is directed to a compound having the formula wherein R1, R2, R3, R4, G, and Q are defined herein. The compounds of the present invention are useful as inhibitors of protein kinases. The present invention is also directed to compositions comprising a compound according to the above formula. The present invention is also directed to compounds that stabilize the open conformation of a protein kinase, a crystallized protein kinase in the open conformation, and uses thereof. The compounds and compositions described herein are useful for treating and preventing an inflammatory condition or disease.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: November 3, 2009
    Assignee: Locus Pharmaceuticals, Inc.
    Inventors: Enrique Luis Michelotti, William R. Moore, Jr., Eric Bruce Springman
  • Publication number: 20090192307
    Abstract: The present invention is directed to a compound having the formula wherein R1, R2, R3, R4, G, and Q are defined herein. The compounds of the present invention are useful as inhibitors of protein kinases. The present invention is also directed to compositions comprising a compound according to the above formula. The present invention is also directed to compounds that stabilize the open conformation of a protein kinase, a crystallized protein kinase in the open conformation, and uses thereof. The compounds and compositions described herein are useful for treating and preventing an inflammatory condition or disease.
    Type: Application
    Filed: December 7, 2005
    Publication date: July 30, 2009
    Inventors: Enrique Luis Michelotti, William R. Moore, JR., Eric Bruce Springman
  • Publication number: 20080280891
    Abstract: The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein A1 is N or CR1; A3 is N or CR3; A5 is N or CR5; R1, R3-R6 and L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur.
    Type: Application
    Filed: June 27, 2007
    Publication date: November 13, 2008
    Applicant: Locus Pharmaceuticals, Inc.
    Inventors: Martha Kelly, Younghee Lee, Bin Liu, Ted Fujimoto, Joel Freundlich, Bruce D. Dorsey, Gary A. Flynn, Arifa Husain, William R. Moore, Jr.
  • Publication number: 20040190799
    Abstract: A discharge bag for flowable materials is disclosed, having a side discharge spout near the bottom of the bag, allowing for discharge without the requirement for the bag to be hoisted by a forklift or other means, for discharging the materials contained within. The side discharge bag can be conveniently used with a frame assembly that further facilitates the discharge of flowable materials stored in the bag.
    Type: Application
    Filed: July 22, 2003
    Publication date: September 30, 2004
    Applicant: General Electric Company
    Inventors: Kief Hess, William R. Moore, Steve L. Suuk, Michael P. Dawley, Thad P. Leister
  • Patent number: 6355460
    Abstract: The present invention relates to serine protease inhibitors having a P site binding moiety and a divalent cation(s) chelating moiety which are pre-prepared as divalent cation(s) complexes or combined with the serine protease in the presence of divalent cation(s) and methods for identifying and using the inhibitors. The compounds are shown to have high inhibitory activity when complexed to divalent cation(s) and are useful in various processes associated with serine protease isolation and inhibition.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: March 12, 2002
    Assignee: Axys Pharmaceuticals, Inc.
    Inventors: James M. Clark, Kyle Elrod, Thomas E. Jenkins, Bradley A. Katz, William R. Moore, Robert M. Stroud
  • Patent number: 6255091
    Abstract: A method is presented for determining if the inhibition of metal mediated serine proteases can be potentiated by cobalt or zinc ions.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: July 3, 2001
    Assignees: AXYS Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: James M. Clark, Kyle Elrod, Thomas E. Jenkins, Bradley A. Katz, William R. Moore, Robert M. Stroud
  • Patent number: 5489600
    Abstract: The present invention relates to piperidyl amides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: May 25, 1994
    Date of Patent: February 6, 1996
    Inventors: Marion W. Wannamaker, William A. VanSickle, William R. Moore
  • Patent number: 5350758
    Abstract: The present invention relates to piperidyl sulfonamides and sulfoxamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: December 18, 1992
    Date of Patent: September 27, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Marion W. Wannamaker, William A. VanSickle, William R. Moore
  • Patent number: 5278171
    Abstract: The present invention provides certain novel azadecalin amides and thioamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: October 15, 1991
    Date of Patent: January 11, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Marion W. Wannamaker, William A. Van Sickle, William R. Moore
  • Patent number: 5084461
    Abstract: The present invention provides certain novel azadecalin amides and thioamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in need thereof.
    Type: Grant
    Filed: March 27, 1991
    Date of Patent: January 28, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Marion W. Wannamaker, William A. Van Sickle, William R. Moore